Regulatory: Fisher Wallace seeks OIG review of FDA's classification of CES March 1, 2016 By Mark McCarty
Elite French investors pump fresh $55 million into artificial heart Feb. 29, 2016 By John Brosky PARIS — To fund its ramp-up to market, artificial heart maker Paris-based Carmat SA raised €50 million ($55 million) through a reserved capital increase put together by a cluster of elite French institutional investors.Read More
OA trials numerous but endpoints tricky as stakeholders search for another way Feb. 29, 2016 By Marie Powers
International Stroke Conference tPA costs and their impact on AIS therapies addressed at meeting Feb. 29, 2016 By Larry Haimovitch
RSS